Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0293532 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Maximilian Robert Gysan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Several studies have shown that SARS-CoV-2 can induce a massive release of cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in the serum may help to predict disease severity and survival in COVID-19 patients.
Methods
In this prospective trial, 88 patients who were hospitalised for COVID-19 were enrolled. Blood samples for serum peptide measurements were taken at the time closest to hospitalisation, at day 5, 9 and 13 (±1). The concentrations of cytokines (IL-1α, IL-1β, IL-1RA, IL-6, L-7, L-10, IFN-γ and TNF-α), chemokines (CCL-3, CCL-4 and CCL-7) and growth factors (G-CSF, GM-CSF and VEGF) were assessed and correlated with the type of ventilation, occurrence of consolidations on imaging and the level of care.
Results
COVID-19 patients (median age 68 years, IQR 55–77) stayed in hospital between 5–171 days. Compared to patients in the general care unit, patients in the intermediate care unit (IMCU) and intensive care unit (ICU) presented significantly elevated serum IL-6 (p = 0.004) and lower IFN-γ levels (p = 0.005), respectively. The peak inspiratory pressure in ventilated patients correlated positively with IL-1RA, G-CSF and inversely with IFN-γ serum levels (all p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
- Institute for Medical Statistics, Medical University of Vienna, Vienna, Austria.
- Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Maximilian Robert Gysan
Zitieren
APA
Gysan, M. R., Milacek, C., Bal, C., Zech, A., Brugger, J., Milos, R. I., Antoniewicz, L., Idzko, M., & Gompelmann, D. (2023). Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0293532
Vancouver
Gysan MR, Milacek C, Bal C, Zech A, Brugger J, Milos RI, et al. Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial. PLOS ONE. 2023. doi:10.1371/journal.pone.0293532
BibTeX
@article{Gysan2023,
author = {Gysan, Maximilian Robert and Milacek, Christopher and Bal, Christina and Zech, Andreas and Brugger, Jonas and Milos, Ruxandra-Iulia and Antoniewicz, Lukasz and Idzko, Marco and Gompelmann, Daniela},
title = {Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0293532}
}
EUVIMED